Baxiva AG
PrivateLast Round
Accelerator
Feb 23, 2026
Total Funding Raised
$3.19M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Baxiva AG is a biotechnology company that develops next-generation glycoconjugate vaccines to prevent serious infections caused by Gram-negative bacteria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Baxiva AG Comparables
Compare Baxiva AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Omniose | 83% | |
| Glycovax Pharma | 81% | |
| Matrivax Research & Development Corporation | 78% | |
Baxiva AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 23, 2026 | ||||
| Grant | Aug 22, 2025 |
Key People
Founding team and executive leadership
Baxiva AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| Venture Kick | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 3, 2026
Monthly visitors increased 69% MoM, reaching 1.4K.
- Mar 3, 2026
Monthly visitors grew 2090% MoM, from 39 to 854.
Baxiva AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Baxiva AG's valuation, stock price, and market status.